Repair & recovery
KPV
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
Also known as Lysine-Proline-Valine
A short alpha-MSH fragment studied for anti-inflammatory signaling in gut and skin models.
What it is
KPV is the terminal tripeptide of alpha-melanocyte-stimulating hormone. Unlike the parent molecule it does not appear to drive pigmentation, and research interest focuses on its suppression of inflammatory signaling pathways such as NF-κB inside cells.
What it's studied for
- Colitis and intestinal-inflammation animal models
- Skin inflammation and wound models
- Antimicrobial activity in laboratory settings
How it's used in practice
- Studied both orally and topically depending on the target tissue
- Frequently discussed in gut-focused research protocols alongside BPC-157
What you should know before asking about it
- Research use only; no FDA-approved indication
- Human clinical data is minimal
- Inflammation has causes — suppressing signal is not the same as diagnosing it
Frequently asked questions.
- What is KPV?
- KPV is the terminal tripeptide of alpha-melanocyte-stimulating hormone. Unlike the parent molecule it does not appear to drive pigmentation, and research interest focuses on its suppression of inflammatory signaling pathways such as NF-κB inside cells.
- What is KPV studied for?
- Published and ongoing research looks at colitis and intestinal-inflammation animal models; skin inflammation and wound models; antimicrobial activity in laboratory settings. These are areas of study, not promised outcomes.
- Is KPV FDA-approved?
- KPV has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
- How is KPV typically used?
- Studied both orally and topically depending on the target tissue Frequently discussed in gut-focused research protocols alongside BPC-157 Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
- What are the risks and unknowns with KPV?
- Research use only; no FDA-approved indication Human clinical data is minimal Inflammation has causes — suppressing signal is not the same as diagnosing it
Sources
- 1.Published literature on KPV Lysine-Proline-Valine— PubMed, U.S. National Library of Medicine
- 2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
- 3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
- 4.Test directory and patient service center locator— Quest Diagnostics
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.
More in Repair & recovery
BPC-157
A synthetic pentadecapeptide sequence studied in preclinical models of tendon, ligament, muscle and gut-lining repair.
TB-500
A fragment of thymosin beta-4 studied for cell migration, flexibility and scar remodeling in preclinical injury models.
GHK-Cu
A naturally occurring copper-binding tripeptide studied for collagen synthesis, skin quality and gene-expression effects.